Proteome Sciences (LON:PRM) Shares Down 39.4% – Time to Sell?

Proteome Sciences plc (LON:PRM)’s share price fell 39.4% during mid-day trading on Friday . The company traded as low as GBX 1.65 ($0.02) and last traded at GBX 1.91 ($0.03). 6,034,522 shares changed hands during trading, an increase of 2,495% from the average session volume of 232,543 shares. The stock had previously closed at GBX 3.16 ($0.04).

Proteome Sciences Trading Up 14.0%

The company has a market cap of £5.90 million, a PE ratio of -173.91 and a beta of 0.07. The stock’s 50 day moving average is GBX 3.04 and its 200-day moving average is GBX 3.21. The company has a quick ratio of 0.37, a current ratio of 0.20 and a debt-to-equity ratio of -258.66.

Proteome Sciences (LON:PRM) last released its quarterly earnings results on Thursday, September 25th. The company reported GBX (0.73) earnings per share (EPS) for the quarter. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.